5 Patents
- US123715032025Methods of Treatment Using a Leptin Receptor Agonist Antibody
REGENERON PHARMACEUTICALS, Inc.
0 cites - US122757922025Antigen-binding Proteins That Activate the Leptin Receptor
REGENERON PHARMACEUTICALS, Inc.
0 cites - US118345002023Bispecific Antigen Binding Molecules That Bind Leptin Receptor And/or GP130, and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites - US116423902023Method of Treatment with a Fusion Protein Comprising Apelin and an Anti-aplnr Antibody
Regeneran Pharmaceuticals, Inc.
0 cites - US116083812023Methods of Treatment Using a Leptin Receptor Agonist Antibody
REGENERON PHARMACEUTICALS, Inc.
0 cites